In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Cardiovascular toxicity risk stratification and preventive strategies in patients with cancer

Listen to this discussion between Dr. Teresa Lopez-Fernandez from the University Hospital La Paz in Madrid, Spain and Prof. Susan Dent from Duke University, Durham, North Carolina, USA.


The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.